NPI: 1639135379 · KAYENTA, AZ 86033 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/21/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/21/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,638 | $286K |
| 2019 | 12,026 | $278K |
| 2020 | 14,006 | $333K |
| 2021 | 13,764 | $346K |
| 2022 | 12,041 | $331K |
| 2023 | 8,242 | $283K |
| 2024 | 3,996 | $179K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,703 | 2,471 | $1.98M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 334 | 200 | $46K |
| A4657 | Syringe, with or without needle, each | 1,660 | 1,603 | $9K |
| 82728 | 758 | 710 | $379.52 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,911 | 1,457 | $262.43 |
| 82108 | 193 | 186 | $109.88 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,678 | 1,302 | $0.00 |
| 83550 | 743 | 697 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 252 | 132 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 14 | 14 | $0.00 |
| 90674 | 75 | 74 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 93 | 93 | $0.00 |
| 90677 | 16 | 16 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 6,206 | 1,752 | $0.00 |
| 85048 | 1,533 | 1,403 | $0.00 | |
| 85041 | 1,510 | 1,419 | $0.00 | |
| 83970 | 1,243 | 1,125 | $0.00 | |
| 83540 | 778 | 731 | $0.00 | |
| 90662 | 13 | 13 | $0.00 |